Subscribe
shutterstock_596091488_1000_words
1000 words / Shutterstock.com
25 September 2019EuropeRory O'Neill

UK Labour promises public generics company, compulsory drug licensing

Jeremy Corbyn, leader of the UK Labour Party, has pledged to create a publicly-owned drugs manufacturer and use compulsory licensing to sell generic, lower priced versions of drugs to the country’s National Health Service (NHS).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Labour peer says vaccine IP should be waived during a pandemic
1 February 2022   UK politicians are proposing that the country waive UK registered IP related to vaccines and treatments in the event of a pandemic.
Generics
Russian government approves compulsory drug licensing bill
19 November 2019   The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.
Generics
China awards generics contracts to lowest bidders
26 September 2019   China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025

More on this story

Big Pharma
Labour peer says vaccine IP should be waived during a pandemic
1 February 2022   UK politicians are proposing that the country waive UK registered IP related to vaccines and treatments in the event of a pandemic.
Generics
Russian government approves compulsory drug licensing bill
19 November 2019   The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.
Generics
China awards generics contracts to lowest bidders
26 September 2019   China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.

More on this story

Big Pharma
Labour peer says vaccine IP should be waived during a pandemic
1 February 2022   UK politicians are proposing that the country waive UK registered IP related to vaccines and treatments in the event of a pandemic.
Generics
Russian government approves compulsory drug licensing bill
19 November 2019   The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.
Generics
China awards generics contracts to lowest bidders
26 September 2019   China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.

More features

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims